Skip to main content

XPH

ETF

XPH

ETF
—
—

Performance overview

XPH Price
Price Chart

Forward-looking statistics

Beta
0.81
Risk
18.81%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Fund Profile

—

Fund info

—

Investing methodUnknown
DiversifiedNo
Expense ratio0.35%
Asset classUnknown

Company info

Sector—
Industry—
Website—
AUM—

Security info

ExchangeNyse American
Type of shareN/A
Earnings per share (EPS)—
Dividend per share—
Revenue per share—
Avg trading volume (30 day)—
Avg trading volume (10 day)—
Put-call ratioN/A

Macro factor sensitivity

Growth+1.4
Credit+3.3
Liquidity-0.4
Inflation-1.3
Commodities-0.0
Interest Rates-1.2

Upcoming events

Next earnings day—
Next dividend day—
Ex. dividend day—

News

ETFs on the Move Post U.S.-China Trade Deal

Let's delve into the ETF world following the 90-day U.S.-China trade deal.

Zacks Investment Research (May 12, 2025)
Are Your Health Care ETFs Safe? Trump's New Policies May Trigger Shockwaves Across Pharma Stocks

As the drug industry is in the middle of a growing policy maelstrom in Washington, D.C., investors are closely watching pharmaceutical ETFs to measure market sentiment and ride out the emerging volatility.

Benzinga (May 8, 2025)
BMO's Siegerman talks the impact of tariffs on pharmaceutical stocks

Evan Seigerman, BMO, joins 'Fast Money' to talk the impact of tariffs on pharma space.

CNBC Television (April 9, 2025)
Pharma market investments: How ETFs help you dabble in the sector at a modest price

Some health care sector ETFs have exposure to companies like Johnson & Johnson, Pfizer, UnitedHealth

Fox Business (July 2, 2022)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free